Q2 2023 Earnings Presentation

ResMed | The global leader in connected and digital health Key Statistics¹ Headquarters Founded San Diego, CA 1989 11% 11% Revenue LTM 2Q23 revenue $3.8B 36% by business 53% LTM 2Q23 30% Revenue by region LTM 2Q23 59% Listed (NYSE, ASX) 1995, RMD Market cap ~$35B Countries served 140+ >10,000 Devices ■ Masks & Other ■ OOH SaaS ■U.S., Canada, and Latin America ■ Europe, Asia, and Other ■ OOH SaaS (U.S. & Germany) Total employees Our businesses Sleep Apnea Delivering a market-leading patient experience through innovative solutions that lower overall costs for treating sleep apnea patients and improve clinical outcomes by leveraging global digital health solutions. Respiratory Care Improving the lives of patients with COPD, asthma, and other key chronic respiratory diseases on their healthcare journey - lowering costs, preventing hospitalization, and creating end-to-end care solutions Software as a Service (SaaS) Providing a network out-of-hospital healthcare SaaS management solutions that help providers deliver more personalized care, measurable results, and improved health outcomes across large populations 1As of 12/31/2022 4 2023 ResMed | Q2 2023 Earnings Presentation - Jan. 26, 2023 ResMed

View entire presentation